Clinical Trial of Avasopasem in Patients With Metastatic Hormone Receptor Positive Breast Cancer With Progression on a CDK 4/6 Inhibitor and Hormonal Therapy

NCT07137871 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer Metastatic

Interventions

DRUG: Avasopasem

Sponsor

The University of Texas Health Science Center at San Antonio